Adenosine kinase is a key determinant for the anti-HCV activity of ribavirin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adenosine kinase is a key determinant for the anti-HCV activity of ribavirin

Published:2013-08-19 Issue:4 Volume:58 Page:1236-1244
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Mori Kyoko¹,Hiraoka Osamu²,Ikeda Masanori¹,Ariumi Yasuo¹,Hiramoto Akiko³,Wataya Yusuke³,Kato Nobuyuki¹

Affiliation:

1. Department of Tumor Virology; Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences; Okayama; Japan

2. School of Pharmacy; Shujitsu University; Okayama; Japan

3. Department of Drug Informatics; Faculty of Pharmaceutical Sciences; Okayama University; Okayama; Japan

Publisher

Wiley

Subject

Hepatology

Reference20 articles.

1. Unravelling hepatitis C virus replication from genome to function;Lindenbach;Nature,2005

2. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases;Ghany;Hepatology,2011

3. Telaprevir for previously untreated chronic hepatitis C virus infection;Jacobson;N Engl J Med,2011

4. Boceprevir for untreated chronic HCV genotype 1 infection;Poordad;N Engl J Med,2011

5. Mechanism of action of interferon and ribavirin in treatment of hepatitis C;Feld;Nature,2005

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Galactose: A Versatile Vector Unveiling the Potentials in Drug Delivery, Diagnostics, and Theranostics;Pharmaceuticals;2024-02-27

2. Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine;Haematologica;2023-03-23

3. Separate Evaluation of Fraction Absorbed and Intestinal Availability after Oral Administration of Drugs Based on the Measurement of Portal and Systemic Plasma Concentrations and Luminal Concentration;Molecular Pharmaceutics;2023-03-14

4. Hepatitis C virus (HCV) : Development of anti-HCV agents and anti-HCV therapy;Okayama Igakkai Zasshi (Journal of Okayama Medical Association);2020-12-01

5. Genetic determinants of COVID-19 drug efficacy revealed by genome-wide CRISPR screens;2020-10-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3